These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1825400)

  • 1. Inhibition by FCE 22178 of platelet and glomerular thromboxane synthase in animal and human kidney disease.
    Alessandrini P; Salvati P; Pugliese F; Ciabattoni G; Patrono C
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():707-10. PubMed ID: 1825400
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy.
    Kontessis PS; Jones SL; Barrow SE; Stratton PD; Alessandrini P; De Cosmo S; Ritter JM; Viberti GC
    J Lab Clin Med; 1993 Mar; 121(3):415-23. PubMed ID: 8445289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of renal disease on glomerular proteinases.
    Teschner M; Schaefer RM; Paczek L; Heidland A
    Miner Electrolyte Metab; 1992; 18(2-5):92-6. PubMed ID: 1465087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
    Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
    Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis.
    Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C
    J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of platelet thromboxane synthetase by 1-(3-benzyloxy-1[E]octenyl)imidazole.
    Sincholle D; Coquelet C; Bonne C
    Arzneimittelforschung; 1986; 36(1):117-9. PubMed ID: 3082339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of disease on glomerular proteinases.
    Teschner M; Schaefer RM; Paczek L; Heidland A
    Przegl Lek; 1992; 49(1-2):1-5. PubMed ID: 1454996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of enhanced glomerular synthesis of thromboxane A2 in progressive kidney disease.
    Salvati P; Ferti C; Ferrario RG; Lamberti E; Duzzi L; Bianchi G; Remuzzi G; Perico N; Benigni A; Braidotti P
    Kidney Int; 1990 Sep; 38(3):447-58. PubMed ID: 2232487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders.
    Gresele P; Blockmans D; Deckmyn H; Vermylen J
    J Pharmacol Exp Ther; 1988 Jul; 246(1):301-7. PubMed ID: 3134542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology and biochemistry of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():235-40. PubMed ID: 6221529
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
    Remuzzi G; Imberti L; Rossini M; Morelli C; Carminati C; Cattaneo GM; Bertani T
    J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole-blood assays for evaluation of thromboxane synthase inhibition.
    Spokas EG; Nicholson NS; Suleymanov OD; Walsh GM; Tuffin D
    Methods Mol Biol; 1999; 120():249-56. PubMed ID: 10343321
    [No Abstract]   [Full Text] [Related]  

  • 13. Alterations of glomerular and extracellular glutathione peroxidase levels in patients and rats with focal segmental glomerulosclerosis.
    Chen HC; Guh JY; Lai YH
    J Lab Clin Med; 2001 Apr; 137(4):279-83. PubMed ID: 11283522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of dazoxiben, a selective thromboxane-synthase inhibitor, on platelet and renal prostaglandin-endoperoxide metabolism.
    Patrignani P; Filabozzi P; Catella F; Pugliese F; Patrono C
    J Pharmacol Exp Ther; 1984 Feb; 228(2):472-7. PubMed ID: 6537977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary protein and the progression of renal disease.
    Meyer TW; Lawrence WE; Brenner BM
    Kidney Int Suppl; 1983 Dec; 16():S243-7. PubMed ID: 6588259
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of a thromboxane A2 synthase inhibitor on the dyslipoproteinemia of an inbred rat strain with spontaneous age-related nephrotic syndrome.
    Tarugi P; Nicolini S; Albertazzi L; Marchi L; Calandra S; Salvati P
    Aging (Milano); 1994 Oct; 6(5):381-90. PubMed ID: 7893785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.
    Tobias LD; Hamilton JG
    Adv Prostaglandin Thromboxane Res; 1980; 6():453-6. PubMed ID: 6770605
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of converting enzyme and thromboxane synthetase in a model of progressive renal disease; effects of enalapril and RS-86328 in the rat.
    Rosenkranz RP; Hayashi CM
    Proc West Pharmacol Soc; 1988; 31():81-5. PubMed ID: 2850566
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.
    Macconi D; Benigni A; Morigi M; Ubiali A; Orisio S; Livio M; Perico N; Bertani T; Remuzzi G; Patrono C
    J Lab Clin Med; 1989 May; 113(5):549-60. PubMed ID: 2541212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of N,N'-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human platelets.
    Gresele P; Deckmyn H; Arnout J; Nenci GG; Vermylen J
    Thromb Haemost; 1989 Jun; 61(3):479-84. PubMed ID: 2552606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.